Perspectives

Our perspectives on the problems life sciences cannot afford to get wrong.

Filter

Topics

AI & Digital

AI Is Not Ready to Be the Decision-Maker, And Pretending Otherwise Is the Real Risk

Stop Asking Build vs. Buy: Most Biotechs Don't Have an AI Strategy at All

The Portfolio Imperative: Converting AI Investment into Compounding Enterprise Value

Why AI Fails to Scale in Biopharma: 3 Breaking Points for the C-Suite

AI vs Automation in Biopharma: A 5-Point Framework for Biopharma Operations

AI's Impact on Life Science Partnerships: Time, Cost, and Strategic Benefits

AI and Drug Discovery: The Virtual Lab’s Role in Revolutionizing Biopharma R&D

The Evolving World of Global Regulatory Affairs: The Interplay between Harmonization, RWE/RWD, and AI

Prev

1 2